KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug, the first on-demand oral treatment for a type of hereditary swelling disorder, sending its shares ...

Here are six new drug shortages and discontinuations, according to drug supply databases from the FDA.

Fixed once-daily low doses of amlodipine 5mg and candesartan cilexetil 8mg were compared during 8–12 weeks of treatment. [8, 9, 10] There have also been a number of uptitration studies including ...

Detailed list of Maruti cars under 10 Lakh in India as on Jul 2025. Make buying decision based on details like price, images, mileage, reviews, specs, & variant list for model cars between 6 to 10 ...

The new MG HS is going electric with an all-new plug-in hybrid system. We've had a chance to test drive a pre-production version of the Super Hybrid system ahead of its Australian launch late this ...

The FDA has approved a new pill called Widaplik, which combines three drugs – telmisartan, amlodipine, and indapamide – to treat adults who have high blood pressure.

A new era of hypertension treatment is on the horizon for U.S. | The drug is the first triple-combo pill for the initial treatment of hypertension in the U.S.

London, UK, Boston, MA, 9 June 2025 – George Medicines, a late-stage biopharmaceutical company focused on addressing unmet needs in cardiometabolic disease, today announces that the US Food and ...

The Food and Drug Administration (FDA) has approved Widaplik ™ (telmisartan, amlodipine and indapamide), a single pill combination therapy, for the treatment of hypertension, including as ...